This chapter provides an overview of methods for the measurement of hepatic blood flow for the
whole liver and hepatic blood perfusion per unit volume of liver tissue. Measurement of the total flow rate is
performed by intravenous infusion of a test substance that is eliminated only by the liver, measurements of
steady-state arterial and liver venous concentration differences across the organ and calculation by Fick’s
principle. Indocyanine green (ICG) has been validated as a suitable test substance for such measurements in
studies using pigs and is widely used in human studies. Steady-state clearance measurements can be used to
measure the total hepatic flow rate for substances with a liver vein concentration that is negligible when
compared to the arterial concentration. Sorbitol has been validated as a suitable test substance in healthy
subjects (with corrections for urinary excretion) for such measurements. Currently, no other clearance
methods have proven suitable. Hepatic blood perfusion can be measured by dynamic PET using tracers for
which the permeability of the plasma-hepatocyte membrane is high. Quantification of the hepatic blood
perfusion requires measurements of the supply of tracer from an artery and the inaccessible portal vein, but
methods have been developed that replace the invasive portal venous samples using tissue-derived
information or a portal venous model. The methods have been developed and validated in pig studies and
are promising for transfer to humans. It has been shown that the regional perfusion can be estimated using a
short three-min dynamic PET scan employing the glucose analogue [18F]fluoro-2-deoxy-D-glucose (18FFDG)
by compartmental model analysis. The hepatic blood perfusion can also be estimated using
intravascular tracer 15O-carbon monoxide by microvascular models that account for the tracer concentration
gradient along the liver sinusoids.
Keywords: Liver hemodynamics; PET kinetics; Indocyanine green; Sorbitol; 18F-FDG.
